KRT18 and metabolic dysfunction-associated steatotic liver disease: Similarly, continuous increases in both CK18‐M30 and CK18‐M65 levels have been observed in NAFLD patients with Type 2 diabetes mellitus, supporting their relevance to systemic metabolic disturbance and cardiovascular involvement [30].